Molecular Pharmacology Program

The Jan Grimm Lab

Research

Jan Grimm, MD, PhD
Jan Grimm, MD, PhD

The Grimm lab in the Molecular Pharmacology Program focuses on the development of novel and innovative approaches for cancer diagnostics and therapy. These approaches evaluate underlying biology and utilize nanotechnology, chemistry and physics interrogated with modern imaging methods. The lab focuses currently several avenues: (i) the utilization of nanoparticles for cancer therapy; (ii) novel imaging approaches such as Cerenkov and optoacoustic imaging and (iii) the biology of PSMA both in prostate cancer and neovasculature using a tumor-on-chip microfluidic chip system.

View Lab Overview

Research Projects

The Jan Grimm Lab

Publications

People

Jan Grimm, MD, PhD

Jan Grimm, MD, PhD

  • Radiologist and Nuclear Medicine physician Jan Grimm develops novel approaches for improved diagnosis, monitoring and therapy of prostate and other cancers.
  • MD, University of Hamburg (Germany)
  • PhD, University of Kiel (Germany)
grimmj@mskcc.org
Email Address
646-888-3095
Office Phone
Download CV
PDF File
View physician profile
Physician profile

Members

Jan Grimm

Member/Professor

Anuja Ogirala
Anuja Ogirala

Senior Research Assistant

Charlene Hsu, Research Technician
Charlene Hsu

Senior Research Technician

Elizabeth Isaac
Elizabeth Isaac

Graduate Student- Cornell Pharmacology

B3
Benedict Mc Larney

Graduate Research Assistant

Magdalena Skubal
Magdalena Skubal

Research Scholar

Ali Sonay
Ali Sonay

Research Scholar

Evan Stater
Evan Stater

Graduate Student- Cornell Pharmacology

Ryo Tamura
Ryo Tamura

Research Scholar

Laura Minaya
Laura Vidal

Administrative Assistant

Qize Zhang
Qize Zhang

Graduate Student- Hunter College

Lab Alumni
Lynda Cosgrave, PhD
Lynda Cosgrave

Research Fellow

Charalambos (Bambos) Kaittanis, PhD
Charalambos (Bambos) Kaittanis

Research Fellow

Priyanka Shukla, PhD
Priyanka Shukla

Research Fellow

Daniel Thorek, PhD
Daniel Thorek

Research Fellow

Travis Shaffer
Travis Shaffer

Graduate Student

Kaveeta Sawh, BA
Kaveeta Sawh

Administrative Assistant

Antoni Vilaseca Cabo
Antoni Vilaseca Cabo

Visiting Scientist

Jeremy Cohen, MD
Jeremy Cohen

Research Fellow

Sudeep Das

Research Scholar

Katja Haedicke

Research Scholar

Hannah Lockau
Hannah Lockau

Research Fellow

Camila Longo Machado
Camila Longo Machado

Research Fellow

Candice Thompson
Candice Thompson

Administrative Assistant

Michelle Yip
Tvrtko Hudolin

Research Fellow

Alessandro Ruggiero
Guillaume Normand
Janine Ring

Graduate Research Assistant

Lab Affilations

Achievements

  • 2014- NIH Nagy New Investigator Award
  • 2018- The American Society for Clinical Investigation (ASCI) Member

Get in Touch

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Jan Grimm discloses the following relationships and financial interests:

  • Case Western Reserve University
    Provision of Services
  • Gerson Lehrman Group
    Provision of Services
  • Journal of Nuclear Medicine
    Provision of Services
  • Nortis Bio
    Ownership / Equity Interests
  • Society of Nuclear Medicine
    Provision of Services
  • Technical University of Munich
    Provision of Services (uncompensated)
  • World Molecular Imaging Society
    Provision of Services (uncompensated)

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.


View all disclosures